Stock Market News

Sandoz posts steady FY24 results, cautious FY25 outlook, Biosimilars in focus

Mar 5, 2025 - 09:04
 0
Sandoz posts steady FY24 results, cautious FY25 outlook, Biosimilars in focus
Read More

Tags:

Previous Article

Prada's Bertelli 'very cautious' about possible acquisitions, he tells newspaper

Next Article

USD/CHF remains below 0.8900 following Swiss CPI data release

Related Posts

Diamondback's $4 billion acquisition adds debt but doesn't affect ratings - Moody's

Diamondback's $4 billion acquisition adds debt but does...

Feb 18, 2025  0

Canadian oil tariffs won't immediately affect U.S. imports, says Enbridge CEO

Canadian oil tariffs won't immediately affect U.S. impo...

Mar 4, 2025  0

Nvidia's forecast suggests robust demand from AI heavyweights

Nvidia's forecast suggests robust demand from AI heavyw...

Feb 26, 2025  0